Which approach best ensures that trial processes remain aligned with participant safety and data integrity?

• A. Proportionate to risks and data importance and avoid unnecessary burden
• B. Rigid, one-size-fits-all processes
• C. Focus solely on regulatory compliance
• D. Minimize IRB oversight

Answer: (A)

At the heart of this is applying a risk-based, proportionate approach to how trial processes are designed and run. The idea is to tailor safeguards, monitoring, and documentation to the actual risks participants face and the importance of the data being collected. When controls are proportionate, high-risk aspects get more robust oversight, while low-risk areas receive lighter, but still appropriate, safeguards. This balance helps maintain participant safety and data integrity without creating unnecessary burdens that can slow the trial or introduce errors.

If processes were rigid and one-size-fits-all, they might overprotect some low-risk activities while underprotecting high-risk ones, stifling efficiency and potentially missing safety or quality issues. Focusing only on regulatory compliance can turn essential protections into a box-ticking exercise that doesn’t address real risks or data quality. And minimizing IRB oversight removes a crucial independent check on participant safety and study integrity, which the risk-based approach seeks to preserve through proportionate safeguards.